- $1.10m
- -$3.92m
Annual cashflow statement for GRI Bio, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -4.82 | -9.3 | -7.02 | -13 | -8.21 |
| Depreciation | |||||
| Non-Cash Items | 0.154 | 0.686 | 0.249 | 2.36 | 0.04 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.887 | 0.22 | -0.566 | 1.68 | -0.448 |
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Cash from Operating Activities | -3.71 | -8.31 | -7.13 | -8.99 | -8.61 |
| Capital Expenditures | -0.002 | 0 | — | -0.008 | 0 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | -3.84 | 3.78 | — | — |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -0.002 | -3.84 | 3.78 | -0.008 | 0 |
| Financing Cash Flow Items | 0 | — | — | 0.269 | -2.03 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -0.004 | 15.7 | 3.43 | 10.8 | 11.8 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -3.71 | 3.59 | 0.079 | 1.8 | 3.22 |